Barclays BCS
$22.33 −$0.49 (-2.15%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $22.47 +0.63%
Open$22.33
Prev close$22.82
Day range$22.32 – $22.73
Volume6.83M
Market cap$74.23B
P/E (TTM)8.3
Dividend yield2.72%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in GBP
Revenue£7.37B+2.8% YoY
Net profit£1.90B+11.0% YoY
Diluted EPS£0.49+18.3% YoY
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Annual revenue
Profitability & balance sheet
Net margin22.7%
Return on equity9.2%
Return on assets0.4%
Liabilities / assets95.5%
Cash & investments£253.29B
Total debt£129.72B
Net cash (debt)£123.57B
Where the revenue comes from
Quarter 2026/Q3
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q3 (GBP) |
2026 Q2 (GBP) |
2026 Q1 (GBP) |
2025 ANNUAL (GBP) |
2025 Q4 (GBP) |
|---|---|---|---|---|---|
| Total Operating Revenue | £7.37B | £8.34B | £8.16B | £29.14B | £7.08B |
| Net Interest Income | £3.91B | £3.92B | £3.74B | £14.50B | – |
| -Interest Income | £3.91B | £3.92B | £3.74B | £36.19B | – |
| Non-Interest Income | £3.46B | £4.42B | £4.43B | £14.64B | – |
| -Fees and Commissions | £3.46B | £4.42B | £4.43B | £4.70B | – |
| Other Income (Expense) | -£165.00M | -£1.00M | -£83.00M | -£873.00M | -£597.00M |
| Special Income (Charges) | -£185.00M | -£4.00M | -£104.00M | -£939.00M | -£597.00M |
| -Less:Other Special Charges | £185.00M | £4.00M | £104.00M | £720.00M | £378.00M |
| Other Non-Operating Income (Expenses) | £20.00M | £3.00M | £21.00M | – | – |
| Pretax Profit | £2.32B | £3.25B | £2.81B | £9.14B | £1.86B |
| Tax | £422.00M | £731.00M | £638.00M | £1.93B | £388.00M |
| Net Profit | £1.90B | £2.52B | £2.18B | £7.21B | £1.47B |
| Profit from Continuing Operations | £1.90B | £2.52B | £2.18B | £7.21B | £1.47B |
| Minority Interests | £0.00 | £19.00M | £0.00 | £41.00M | £18.00M |
| Net Income to Parent Company | £1.90B | £2.50B | £2.18B | £7.17B | £1.45B |
| Other Preferred Stock Dividends | £254.00M | £243.00M | £244.00M | £997.00M | £258.00M |
| Net Income to Common Stockholders | £1.65B | £2.26B | £1.93B | £6.18B | £1.20B |
| Basic EPS | £0.49 | £0.67 | £0.56 | £1.75 | £0.34 |
| Diluted EPS | £0.49 | £0.67 | £0.56 | £1.69 | £0.34 |
| Dividend Per Share | £0.24 | £0.00 | £0.22 | £0.35 | £0.00 |
| -Interest Expense | – | – | – | £21.69B | – |
| -Dividend Income | – | – | – | £0.00 | – |
| Selling and Admin Expenses | – | – | – | £2.73B | – |
| -Selling & Marketing Expense | – | – | – | £618.00M | – |
| -General & Admin Expense | – | – | – | £2.11B | – |
| -Depreciation & Amortization | – | – | – | £1.76B | – |
| Income from Associates & Other Participating Interests | – | – | – | £66.00M | – |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | £199.00M | – |
| -Less:Impairment of Capital Assets | – | – | – | £20.00M | – |
Balance sheet
| Line item | 2026 Q3 (GBP) |
2026 Q2 (GBP) |
2026 Q1 (GBP) |
2025 ANNUAL (GBP) |
2025 Q4 (GBP) |
|---|---|---|---|---|---|
| Total Assets | £1.74T | £1.73T | £1.69T | £1.54T | £1.54T |
| Cash, Cash Equivalents & Federal Funds Sold | £265.34B | £257.96B | £246.91B | £379.86B | £379.86B |
| -Cash and Cash Equivalents | £253.29B | £245.86B | £235.35B | £229.75B | £229.75B |
| -Money Market Investments | £12.05B | £12.10B | £11.56B | £150.11B | £150.11B |
| -Trading Securities | £215.99B | £210.10B | £191.05B | £177.81B | £177.81B |
| -Available for Sale Securities | £152.99B | £156.53B | £151.42B | £140.50B | £140.50B |
| Long Term Equity Investment | £751.00M | £732.00M | £760.00M | £739.00M | £739.00M |
| Derivative Assets | £308.97B | £303.60B | £286.39B | £252.46B | £252.46B |
| Net Loan | £383.68B | £371.30B | £370.30B | £423.81B | £423.81B |
| -Allowance for Loans and Lease Losses | £5.36B | £5.52B | £5.58B | £5.29B | £5.29B |
| Goodwill and Other Intangible Assets | £8.99B | £8.91B | £8.36B | £8.28B | £8.28B |
| Assets Held for Sale | £0.00 | £0.00 | £5.56B | £5.93B | £5.93B |
| Other Assets | £13.61B | £5.91B | £12.26B | £5.24B | £5.24B |
| Total Liabilities | £1.66T | £1.65T | £1.62T | £1.47T | £1.47T |
| Total Deposits | £599.26B | £594.36B | £587.59B | £634.57B | £634.57B |
| Derivative Product Liabilities | £298.34B | £291.79B | £272.78B | £240.81B | £240.81B |
| Trading Liabilities | £84.11B | £78.41B | £82.91B | £57.74B | £57.74B |
| Payables | £992.00M | £1.02B | £1.17B | £5.35B | £5.35B |
| -Total Tax Payable | £992.00M | £1.02B | £1.17B | £868.00M | £868.00M |
| Long Term Debt and Capital Lease Obligation | £129.72B | £137.94B | £136.84B | £219.94B | £219.94B |
| Other Liabilities | £220.32B | £223.16B | £214.73B | £301.21B | £301.21B |
| Total Equity | £77.55B | £79.81B | £77.12B | £78.24B | £78.24B |
| Stockholders' Equity | £77.10B | £79.36B | £76.67B | £77.78B | £77.78B |
| Capital Stock | £4.17B | £4.19B | £4.22B | £3.47B | £3.47B |
| -Common Stock | £4.17B | £4.19B | £4.22B | £3.47B | £3.47B |
| Retained Earnings | £60.72B | £60.40B | £58.85B | £59.25B | £59.25B |
| Other Equity Interests | £13.28B | £13.28B | £12.71B | £12.73B | £12.73B |
| Minority Interests | £454.00M | £453.00M | £452.00M | £452.00M | £452.00M |
| Net PPE | – | £4.23B | – | £3.68B | £3.68B |
| Defined Pension Benefit | – | £3.32B | – | £3.31B | £3.31B |
| -Gross PPE | – | – | – | £8.28B | £8.28B |
| -Accumulated Depreciation | – | – | – | -£4.60B | -£4.60B |
| -Goodwill | – | – | – | £4.42B | £4.42B |
| -Other Intangible Assets | – | – | – | £3.87B | £3.87B |
| -Other Payable | – | – | – | £4.48B | £4.48B |
| Additional Paid-In Capital | – | – | – | £711.00M | £711.00M |
Cash flow
| Line item | 2025 ANNUAL (GBP) |
2024 ANNUAL (GBP) |
2023 ANNUAL (GBP) |
2022 ANNUAL (GBP) |
2021 ANNUAL (GBP) |
|---|---|---|---|---|---|
| Operating Cash Flow | £18.74B | £7.11B | -£927.00M | £30.23B | £48.92B |
| Net Income from Continuing Operations | £9.14B | £8.11B | £6.56B | £7.01B | £8.19B |
| Other Non-Cash Items | £6.19B | £2.38B | £10.73B | -£13.30B | £3.09B |
| Change in Working Capital | -£61.00M | -£6.33B | -£21.90B | £32.42B | £37.04B |
| -Change in Loans | -£23.61B | -£14.02B | £4.04B | -£14.59B | £27.39B |
| -Change in Other Current Assets | £22.46B | -£11.36B | £38.43B | -£12.37B | -£17.68B |
| -Change in Other Current Liabilities | -£1.08B | -£2.30B | -£2.36B | £1.05B | £1.25B |
| Net cash flow from investing | £1.60B | -£17.89B | -£23.41B | -£21.67B | £4.27B |
| Net PPE Purchase and Sale | -£1.86B | -£1.57B | -£1.72B | -£1.75B | -£1.72B |
| Net Business Purchase and Sale | £0.00 | -£460.00M | -£2.42B | £0.00 | £1.06B |
| Net Investment Purchase and Sale | £3.22B | -£18.60B | -£19.30B | -£20.01B | £4.93B |
| Net Other Investing Changes | £234.00M | £2.75B | £23.00M | £86.00M | £7.00M |
| Financing Cash Flow | £2.26B | £784.00M | -£1.39B | £696.00M | £107.00M |
| Net Issuance Payments of Debt | £6.91B | £6.40B | £2.87B | £3.60B | £2.02B |
| Net Common Stock Issuance | -£2.37B | -£3.35B | -£2.00B | -£928.00M | -£556.00M |
| Cash Dividends Paid | -£2.25B | -£2.26B | -£2.26B | -£1.98B | -£1.36B |
| Net Other Financing Activities | -£40.00M | – | – | – | – |
| Ending Cash Balance | £256.46B | £235.61B | £248.01B | £278.79B | £259.21B |
| Net Change in Cash | £22.59B | -£9.99B | -£25.73B | £9.25B | £53.30B |
| Beginning Cash Balance | £235.61B | £248.01B | £278.79B | £259.21B | £210.14B |
| Effect of Exchange Rate Changes | -£1.74B | -£2.41B | -£5.05B | £10.33B | -£4.23B |
| Free Cash Flow | £16.88B | £5.54B | -£2.65B | £28.49B | £47.20B |
No comments yet — be the first to weigh in on BCS.
Sign in to join the discussion.